BRACARDA, SERGIO
 Distribuzione geografica
Continente #
NA - Nord America 190
EU - Europa 137
AS - Asia 83
SA - Sud America 11
AF - Africa 1
Totale 422
Nazione #
US - Stati Uniti d'America 187
IE - Irlanda 51
HK - Hong Kong 35
IT - Italia 30
SG - Singapore 30
RU - Federazione Russa 13
CN - Cina 12
FI - Finlandia 9
BR - Brasile 8
DE - Germania 8
UA - Ucraina 8
FR - Francia 5
PL - Polonia 3
BE - Belgio 2
GB - Regno Unito 2
KR - Corea 2
NL - Olanda 2
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
CA - Canada 1
CZ - Repubblica Ceca 1
JP - Giappone 1
MX - Messico 1
NG - Nigeria 1
NO - Norvegia 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
SE - Svezia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 422
Città #
Dublin 51
Hong Kong 35
Chandler 29
Boardman 21
Singapore 20
Houston 19
Moscow 8
San Mateo 8
Santa Clara 8
Ann Arbor 6
Jacksonville 6
Perugia 6
Altamura 4
Beijing 4
Medford 4
Princeton 4
Turku 4
Des Moines 3
Helsinki 3
Lawrence 3
Paris 3
Redwood City 3
Szczecin 3
Andover 2
Ashburn 2
Brussels 2
Dallas 2
Falls Church 2
Los Angeles 2
Milan 2
Norwalk 2
Redmond 2
Seoul 2
Terni 2
Amsterdam 1
Ancona 1
Asunción 1
Berlin 1
Brasília 1
Brescia 1
Brooklyn 1
Cergy 1
Chaguanas 1
Chattanooga 1
Cincinnati 1
Concepción 1
Edinburgh 1
Falkenstein 1
Frankfurt am Main 1
Friesland 1
Hebron 1
Izmir 1
Jaguarão 1
La Paz 1
Lagos 1
Lahore 1
Mexico City 1
Munich 1
Nanjing 1
Nuremberg 1
Olomouc 1
Pescara 1
Porto Alegre 1
Prato 1
Rio de Janeiro 1
Rome 1
Santa Maria da Vitória 1
Savona 1
Selargius 1
Simi Valley 1
St Louis 1
São Luís 1
São Paulo 1
The Dalles 1
Tokyo 1
Toronto 1
Valença 1
Wilmington 1
Totale 321
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 110
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 74
Targeting of EGFR tyrosine kinase by ZD1839 (“Iressa”) in androgen-responsive prostate cancer in vitro 51
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: Results from an Italian, prospective, observational study (the Pros-IT CNR study) 49
STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell Lung Cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial 46
The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study 46
Ad hoc afatinib in an eldery lung cancer patient with EGFR exon 19 deletion L747-A750>P 42
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 31
Totale 449
Categoria #
all - tutte 2.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/202125 2 3 0 3 9 0 2 2 1 1 2 0
2021/202236 1 5 0 1 0 0 2 9 1 1 2 14
2022/2023130 5 16 0 9 7 17 0 6 57 0 8 5
2023/202486 6 6 5 5 0 1 18 0 16 4 7 18
2024/2025121 3 17 4 6 11 8 12 13 18 4 14 11
Totale 449